Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...

Plans to buy Bolt Medical, Inc., a developer of intravascular lithotripsy equipment for treating hardened coronary and peripheral artery disease, were announced by Boston Scientific Corporation ...

Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 2% over the past month. The stock hit a new 52-week high of $92.42 in the ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...

We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and its hardware for breaking through hardened and clogged arteries.

Boston Scientific initially developed the concept for the Bolt IVL system which helped establish Bolt Medical in 2019. As a strategic investor in Bolt Medical, Boston Scientific has an equity ...